doi.org/10.1016/S1535-6108(03)00003-5, hdl.handle.net/1765/55800
Cancer Cell
Department of Pediatrics

Armstrong, S., Kung, A., Mabon, M., Silverman, L., Stam, R., den Boer, M., Pieters, R., Kersey, J., Sallan, S., Fletcher, J., Golub, R., Griffin, J.& Korsmeyer, S. J. (2003). Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification. Cancer Cell, 3(2), 173–183.https://doi.org/10.1016/S1535-6108(03)00003-5